ESMO 2023: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery…
Browsing: ESMO
ESMO 2023: Better use of existing drugs increases cervical cancer survival and reduces recurrence
The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre,…
ESMO 2023: Cemiplimab neoadjuvant treatment demonstrates encouraging event-free survival in patients with resectable cutaneous squamous cell carcinoma
Regeneron Pharmaceuticals, Inc. today announced the first presentation of key secondary endpoints for an investigational…
ESMO 2023: Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus
A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup…
ESMO 2023: Adding immunotherapy to chemotherapy regimen improves survival in metastatic bladder cancer patients
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy…
ESMO 2023: Kidney cancer study shows improved outcomes for patients with advanced disease when treated with belzutifan over everolimus
Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the…
ESMO 2023: The potential of AI to improve cancer care is only going to grow
Artificial intelligence (AI) has made a grand entrance into the public debate this year, but…
ESMO 2023: Air pollution and breast cancer risk – a link that calls for political action
Women living and working in places with higher levels of fine particle air pollution are…
Prediction tool developed to determine benefit of blood cancer treatment
Since its introduction in 2015, a prediction tool developed by the European Society of Medical…
ESMO launches ‘Living Guidelines’ to enhance the usability of its clinical practice guidelines in routine cancer patient care
ESMO, the leading professional organisation for medical oncology, today announced the launch of a new…